Singapore markets closed

Straits Times Index
3,296.89
+4.20(+0.13%)
S&P 500
5,043.35
+24.96(+0.50%)
Dow
38,033.45
+130.16(+0.34%)
Nasdaq
15,740.17
+134.69(+0.86%)
Bitcoin USD
58,432.78
+1,006.58(+1.75%)
CMC Crypto 200
1,267.65
-3.09(-0.24%)

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - Nasdaq Real-time price. Currency in USD

Add to watchlist

13.86

-0.12

(-0.86%)

As of 09:42AM EDT. Market open.

Loading interactive chart…

Business Wire
Teva’s 2023 Healthy Future Report Showcases Renewed Sustainability Strategy and Ambitious Targets
TEL AVIV, Israel, May 02, 2024--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today published its 2023 Healthy Future Report, sharing its actions to promote healthy people, a healthy planet and a healthy business. The report unveils new targets to achieve net zero emissions across Teva’s operations and value chain by 2045 and 100% renewable electricity across all Teva sites by 2035, as well as to reach 200% more total beneficiaries of health system strengthening and capacity building
Thomson Reuters StreetEvents
Q1 2024 Corcept Therapeutics Inc Earnings Call
Q1 2024 Corcept Therapeutics Inc Earnings Call
GuruFocus.com
Corcept Therapeutics Inc (CORT) Q1 2024 Earnings Call Transcript Highlights: Strong Growth Amid ...
Corcept reports a robust financial performance and advances in clinical trials, despite facing potential generic competition.